Skip to content
  • COMPANY
    • OVERVIEW
    • TOPICA TEAM
  • LULICONAZOLE
    • PRODUCT PROFILE
    • ONYCHOMYCOSIS
  • RESEARCH / TRIALS
    • OVERVIEW
    • PUBLICATIONS
  • INVESTORS
  • NEWS
  • CONTACT
  • 35 MILLION PATIENTS IN THE U.S. ALONE ARE SUFFERING FROM ONYCHOMYCOSIS SOLUTIONS FOR AN UNMET NEED
  • THOUSANDS OF CLINICANS WANT A NEW TOPICAL TREATMENT THAT’S SAFE AND EFFECTIVE SOLUTIONS FOR CLINICAL CHALLENGES
  • IT’S TIME FOR LULICONAZOLE THE POTENT ANTIFUNGAL THAT RAPIDLY PENETRATES THE NAIL SOLUTIONS WITH A NOVEL APPROACH
  • TOPICA PHARMACEUTICALS SOLUTIONS BEYOND THE SURFACE ABOUT THE COMPANY
HOT TOPICS
Topica Presents Promising Luliconazole 10% Solution Data at 2012 AAD Annual Meeting... [Read More]          

ONYCHOMYCOSIS

treatment challenges
– see clinician videos

LULICONAZOLE

unique molecular profile
with dual mode of action

RESEARCH & TRIALS

preclinical data
phase 1/2a highlights

UNMET NEED

serving the multibillion
dollar U.S. market

©2012 Topica Pharmaceuticals, Inc. All rights reserved.

  • HOME
  • SITE MAP
  • LEGAL
  • CONTACT